• leader board size
Legal Affairs2020-11-19T22:21:35-08:00

Legal Affairs

Compass Completes FDA Application for COMP360

LONDON / JERSEY CITY – Compass Pathways announced it has completed its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for COMP360, a synthetic psilocybin formulation, for treatment-resistant depression (TRD). If ...

Vireo Growth Reports Q3 2026 Financial Results

MINNEAPOLIS – Vireo Growth Inc. reported third-quarter revenue of $253.7 million, up 177% from $91.7 million a year earlier. Acquisitions drove the increase. Cannabis sales reached $198.1 million, and an agricultural supply business the company ...

Vireo Completes FLUENT Acquisition

MINNEAPOLIS – Vireo Growth Inc. has closed its acquisition of FLUENT Corp., absorbing the vertically integrated multi-state Cannabis operator through a court-approved arrangement. Under the final terms, Vireo acquired all issued and outstanding common shares ...

Vireo Completes FLUENT Acquisition

MINNEAPOLIS – Vireo Growth Inc. has closed its acquisition of FLUENT Corp., absorbing the vertically integrated multi-state Cannabis operator through a court-approved arrangement. Under the final terms, Vireo acquired all issued and outstanding common shares ...

Village Farms Reports Q3 2026 Financial Results

VANCOUVER – Village Farms International Inc. reported record Cannabis revenue of $55 million for the third quarter, up 3% from a year earlier. The company generated consolidated sales of $66.9 million for the three months ...

Cresco Labs Reports Q3 2026 Financial Results

CHICAGO – Cresco Labs Inc. announced third-quarter net revenue of $173 million, a 5% increase from the $165 million recorded during the same period last year and roughly unchanged from the second quarter. Retail sales ...

Compass Completes FDA Application for COMP360

LONDON / JERSEY CITY – Compass Pathways announced it has completed its New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for COMP360, a synthetic psilocybin formulation, for treatment-resistant depression (TRD). If ...

Vireo Growth Reports Q3 2026 Financial Results

MINNEAPOLIS – Vireo Growth Inc. reported third-quarter revenue of $253.7 million, up 177% from $91.7 million a year earlier. Acquisitions drove the increase. Cannabis sales reached $198.1 million, and an agricultural supply business the company ...

Vireo Completes FLUENT Acquisition

MINNEAPOLIS – Vireo Growth Inc. has closed its acquisition of FLUENT Corp., absorbing the vertically integrated multi-state Cannabis operator through a court-approved arrangement. Under the final terms, Vireo acquired all issued and outstanding common shares ...

Curaleaf Accuses Aurora of Locking Out Its Highest Bidder

STAMFORD – Curaleaf Holdings Inc. came out swinging Monday morning, publicly challenging Aurora Cannabis's latest recommendation that shareholders REJECT its enhanced takeover proposal. In a statement, outlined in the official press release, Curaleaf Chairman and ...

Compass Builds a Commercial Case for COMP360

NEW YORK – Compass Pathways is advancing COMP360, its proprietary synthetic psilocybin for treatment-resistant depression (TRD), through a rolling FDA New Drug Application, with a commercial launch targeted for H1 2027. Alongside the regulatory push, ...

Dutch Medical Cannabis Giant Bedrocan Goes Bankrupt

GRONINGEN – The District Court of Northern Netherlands officially declared Bedrocan bankrupt, after the company sought a suspension of payments in late September, ending a more than two-decade run as the country's sole licensed medical ...

DEA Opens Schedule III Registration Path for Medical Cannabis Operators

WASHINGTON – The Drug Enforcement Administration’s Diversion Control Division has launched the application process, making DEA Form 225 available to state-licensed medical Cannabis manufacturers, distributors, and analytical labs. Manufacturers cover cultivation, production, processing, packaging, labeling ...

Subscribe To Our Newsletter

Go to Top